Cargando…

Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms

INTRODUCTION AND HYPOTHESIS: Epidemiological studies demonstrated that patients suffering from overactive bladder often present with different mental problems, amongst which depression is the most frequently observed. The main goal of our study was to check if the repeated administration of corticos...

Descripción completa

Detalles Bibliográficos
Autores principales: Wróbel, Andrzej, Serefko, Anna, Poleszak, Ewa, Rechberger, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065892/
https://www.ncbi.nlm.nih.gov/pubmed/27142032
http://dx.doi.org/10.1007/s00192-016-3027-3
_version_ 1782460380464807936
author Wróbel, Andrzej
Serefko, Anna
Poleszak, Ewa
Rechberger, Tomasz
author_facet Wróbel, Andrzej
Serefko, Anna
Poleszak, Ewa
Rechberger, Tomasz
author_sort Wróbel, Andrzej
collection PubMed
description INTRODUCTION AND HYPOTHESIS: Epidemiological studies demonstrated that patients suffering from overactive bladder often present with different mental problems, amongst which depression is the most frequently observed. The main goal of our study was to check if the repeated administration of corticosterone (CORT) is able to evoke the depressive-like behaviour and detrusor overactivity (DO) symptoms in rats. Moreover, we investigated whether the acute administration of common antidepressants (imipramine, 30 mg/kg, and fluoxetine, 15 mg/kg), antimuscarinic (oxybutynin chloride, 0.5 mg/kg) or CRF(1) (SN 003, 1 mg/kg) antagonists has an impact on the cystometric parameters, behaviour in the Porsolt test, and overall locomotor activity of animals exposed to CORT. METHODS: The experiments were carried out on female Wistar rats. All applied surgical and histopathology procedures, cystometric investigations, locomotor activity and forced swim measurements have been fully described in the published literature. RESULTS: Fourteen-day administration of CORT may induce both depressive and DO symptoms in rats, which are reversed by the inhibition of CRF(1) receptors. CONCLUSIONS: It seems that the CRF(1) receptor could be an interesting target for overactive bladder pharmacotherapy, particularly in patients with co-existing depression.
format Online
Article
Text
id pubmed-5065892
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-50658922016-10-28 Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms Wróbel, Andrzej Serefko, Anna Poleszak, Ewa Rechberger, Tomasz Int Urogynecol J Original Article INTRODUCTION AND HYPOTHESIS: Epidemiological studies demonstrated that patients suffering from overactive bladder often present with different mental problems, amongst which depression is the most frequently observed. The main goal of our study was to check if the repeated administration of corticosterone (CORT) is able to evoke the depressive-like behaviour and detrusor overactivity (DO) symptoms in rats. Moreover, we investigated whether the acute administration of common antidepressants (imipramine, 30 mg/kg, and fluoxetine, 15 mg/kg), antimuscarinic (oxybutynin chloride, 0.5 mg/kg) or CRF(1) (SN 003, 1 mg/kg) antagonists has an impact on the cystometric parameters, behaviour in the Porsolt test, and overall locomotor activity of animals exposed to CORT. METHODS: The experiments were carried out on female Wistar rats. All applied surgical and histopathology procedures, cystometric investigations, locomotor activity and forced swim measurements have been fully described in the published literature. RESULTS: Fourteen-day administration of CORT may induce both depressive and DO symptoms in rats, which are reversed by the inhibition of CRF(1) receptors. CONCLUSIONS: It seems that the CRF(1) receptor could be an interesting target for overactive bladder pharmacotherapy, particularly in patients with co-existing depression. Springer London 2016-05-03 2016 /pmc/articles/PMC5065892/ /pubmed/27142032 http://dx.doi.org/10.1007/s00192-016-3027-3 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Wróbel, Andrzej
Serefko, Anna
Poleszak, Ewa
Rechberger, Tomasz
Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms
title Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms
title_full Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms
title_fullStr Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms
title_full_unstemmed Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms
title_short Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms
title_sort fourteen-day administration of corticosterone may induce detrusor overactivity symptoms
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065892/
https://www.ncbi.nlm.nih.gov/pubmed/27142032
http://dx.doi.org/10.1007/s00192-016-3027-3
work_keys_str_mv AT wrobelandrzej fourteendayadministrationofcorticosteronemayinducedetrusoroveractivitysymptoms
AT serefkoanna fourteendayadministrationofcorticosteronemayinducedetrusoroveractivitysymptoms
AT poleszakewa fourteendayadministrationofcorticosteronemayinducedetrusoroveractivitysymptoms
AT rechbergertomasz fourteendayadministrationofcorticosteronemayinducedetrusoroveractivitysymptoms